USP5 and hepatocellular carcinoma: In summary, our rescue experiments suggest that LRP11 may contribute to HCC malignant progression through its interactions with USP5 and RACK1, identifying these proteins as potential mediators of LRP11-associated oncogenic processes and as possible therapeutic targets for further investigation in HCC.